112430-63-4|Ganodermic acid S|(R,E)-6-((3S,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid|-范德生物科技公司

Ganodermic acid S

NMR下载 COA and HPLC MSDS下载
names：
(R,E)-6-((3S,5R,10S,13R,14R,15S,17R)-3,15-diacetoxy-4,4,10,13,14-pentamethyl-2,3,4,5,6,10,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylhept-2-enoic acid
CAS号：
112430-63-4
MDL Number：
MF(分子式)： C34H50O6 MW(分子量)： 554.76
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Ganodermic acid S
英文别名	Ganodermic acid S; Ganoderic acid R;
CAS号	112430-63-4
SMILES	CC1(C)[C@@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@H](C)CC/C=C(C)/C(O)=O)C[C@H](OC(C)=O)[C@](C)4C3=CC[C@@]12[H]
Inchi	InChI=1S/C34H50O6/c1-20(11-10-12-21(2)30(37)38)26-19-29(40-23(4)36)34(9)25-13-14-27-31(5,6)28(39-22(3)35)16-17-32(27,7)24(25)15-18-33(26,34)8/h12-13,15,20,26-29H,10-11,14,16-19H2,1-9H3,(H,37,38)/b21-12+/t20-,26-,27+,28+,29+,32-,33-,34-/m1/s1
InchiKey	OTUZGGSAOMCYNC-CRTLAZRUSA-N
分子式 Formula	C34H50O6
分子量 Molecular Weight	554.76
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Ganodermic acid S(CAS:112430-63-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Ganodermic acid S, a membrane acting agent, exerts multiple effects on human platelet function. Ganodermic acid S is isolated from the Chinese medicinal fungus Ganoderma lucidum.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Su CY, Shiao MS, Wang CT. Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem Pharmacol. 1999 Aug 15;58(4):587-95. PubMed PMID: 10413295.

[2]Su C, Shiao M, Wang C. Potentiation of ganodermic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets. Thromb Res. 2000 Jul 15;99(2):135-45. PubMed PMID: 10946087.

[3] Wang CN, Chen JC, Shiao MS, Wang CT. The effect of ganodermic acid S on human platelets. Adv Exp Med Biol. 1990;281:265-9. PubMed PMID: 1966354.

[4] Wang CN, Chen JC, Shiao MS, Wang CT. The aggregation of human platelet induced by ganodermic acid S. Biochim Biophys Acta. 1989 Nov 17;986(1):151-60. PubMed PMID: 2819092.

[5] Su CY, Shiao MS, Wang CT. Predominant inhibition of ganodermic acid S on the thromboxane A2-dependent pathway in human platelets response to collagen. Biochim Biophys Acta. 1999 Feb 25;1437(2):223-34. PubMed PMID: 10064905.

6: Wang CN, Chen JC, Shiao MS, Wang CT. The inhibition of human platelet function by ganodermic acids. Biochem J. 1991 Jul 1;277 ( Pt 1):189-97. PubMed PMID: 1649599; PubMed Central PMCID: PMC1151209.7: Wang FS, Cai H, Yang JS, Zhang YM, Hou CY, Liu JQ, Zhao MJ. [Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst]. Yao Xue Xue Bao. 1997 Jun;32(6):447-50. Chinese. PubMed PMID: 11596326.8: Tang YJ, Zhong JJ. Scale-up of a liquid static culture process for hyperproduction of ganoderic acid by the medicinal mushroom Ganoderma lucidum. Biotechnol Prog. 2003 Nov-Dec;19(6):1842-6. PubMed PMID: 14656165.9: Fang QH, Zhong JJ. Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnol Prog. 2002 Jan-Feb;18(1):51-4. PubMed PMID: 11822899.10: Chen RY, Yu DQ. [Progress of studies on the chemical constituents of Ganoderma triterpene]. Yao Xue Xue Bao. 1990;25(12):940-53. Review. Chinese. PubMed PMID: 2104477.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开